Literature DB >> 20438780

Reducible DNA nanoparticles enhance in vitro gene transfer via an extracellular mechanism.

Wenchao Sun1, Pamela B Davis.   

Abstract

We developed n class="Chemical">polylysine based DNA nanoparticles (DNA NPs) that contain disulfide linkage in the carrier and demonstrated that this reducible DNA NP enhances in vitro gene transfer via an extracellular mechanism. Polylysine was conjugated through an N-terminal cysteine to a polyethylene glycol chain (PEG) by either a disulfide bond (SS) or a thioether bond (CS), and the resulting PEG-peptide conjugates were used to compact plasmid DNA into reducible SS-DNA NPs or non-reducible CS-DNA NPs with identical physical properties. SS-DNA NPs mediated more than 10-fold higher in vitro gene transfer. Others have suggested that disulfide bonds in synthetic gene carriers undergo cleavage in the reducing environment inside the cell, allowing increased intracellular DNA release. In this study, however, both higher cellular uptake of SS-DNA NPs and inhibition of SS-DNA NP mediated in vitro gene transfer by blocking extracellular free thiols suggested an extracellular mechanism. DePEGylation of SS-DNA NPs by extracellular thiols caused aggregation which might lead to higher cellular uptake and higher transgene expression. A series of SS-DNA NPs prepared with stabilized disulfide bonds survived the extracellular environment without aggregation but lost the superior gene transfer ability, indicating that, in our system, intracellular mechanisms are not involved. These results provided further insight into the mechanisms of in vitro gene transfer enhancement by introducing reducible linkages, contributing to the rational design of more efficient non-viral gene delivery systems. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20438780      PMCID: PMC3031909          DOI: 10.1016/j.jconrel.2010.04.031

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  36 in total

Review 1.  Reduction-sensitive polymers and bioconjugates for biomedical applications.

Authors:  Fenghua Meng; Wim E Hennink; Zhiyuan Zhong
Journal:  Biomaterials       Date:  2009-02-05       Impact factor: 12.479

2.  Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine.

Authors:  M A Gosselin; W Guo; R J Lee
Journal:  Bioconjug Chem       Date:  2001 Nov-Dec       Impact factor: 4.774

3.  Downregulation of protein disulfide isomerase inhibits infection by the mouse polyomavirus.

Authors:  Joanna Gilbert; Wu Ou; Jonathan Silver; Thomas Benjamin
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

4.  Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo.

Authors:  Assem-Galal Ziady; Christopher R Gedeon; Timothy Miller; William Quan; Jennifer M Payne; Susannah L Hyatt; Tamara L Fink; Osman Muhammad; Sharon Oette; Tomasz Kowalczyk; Murali K Pasumarthy; Robert C Moen; Mark J Cooper; Pamela B Davis
Journal:  Mol Ther       Date:  2003-12       Impact factor: 11.454

5.  Short biodegradable polyamines for gene delivery and transfection of brain capillary endothelial cells.

Authors:  Hongwei Zhang; Serguei V Vinogradov
Journal:  J Control Release       Date:  2010-01-20       Impact factor: 9.776

6.  Long-term transgene expression in the central nervous system using DNA nanoparticles.

Authors:  David M Yurek; Anita M Fletcher; George M Smith; Kim B Seroogy; Assem G Ziady; Joseph Molter; Tomasz H Kowalczyk; Linas Padegimas; Mark J Cooper
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

7.  In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensates.

Authors:  Kai Y Kwok; Youmie Park; Yongsheng Yang; Donald L McKenzie; Yahong Liu; Kevin G Rice
Journal:  J Pharm Sci       Date:  2003-06       Impact factor: 3.534

8.  Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase.

Authors:  R Mandel; H J Ryser; F Ghani; M Wu; D Peak
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis.

Authors:  Jehangir S Wadia; Radu V Stan; Steven F Dowdy
Journal:  Nat Med       Date:  2004-02-08       Impact factor: 53.440

10.  Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression.

Authors:  Kanjiro Miyata; Yoshinori Kakizawa; Nobuhiro Nishiyama; Atsushi Harada; Yuichi Yamasaki; Hiroyuki Koyama; Kazunori Kataoka
Journal:  J Am Chem Soc       Date:  2004-03-03       Impact factor: 15.419

View more
  12 in total

1.  The transduction of Coxsackie and Adenovirus Receptor-negative cells and protection against neutralizing antibodies by HPMA-co-oligolysine copolymer-coated adenovirus.

Authors:  Chung-Huei K Wang; Leslie W Chan; Russell N Johnson; David S H Chu; Julie Shi; Joan G Schellinger; André Lieber; Suzie H Pun
Journal:  Biomaterials       Date:  2011-09-28       Impact factor: 12.479

2.  Bioreducible polyether-based pDNA ternary polyplexes: balancing particle stability and transfection efficiency.

Authors:  Tsz Chung Lai; Kazunori Kataoka; Glen S Kwon
Journal:  Colloids Surf B Biointerfaces       Date:  2011-09-22       Impact factor: 5.268

Review 3.  Bioreducible polycations in nucleic acid delivery: past, present, and future trends.

Authors:  David Oupický; Jing Li
Journal:  Macromol Biosci       Date:  2014-03-28       Impact factor: 4.979

4.  Cathepsin B-sensitive polymers for compartment-specific degradation and nucleic acid release.

Authors:  David S H Chu; Russell N Johnson; Suzie H Pun
Journal:  J Control Release       Date:  2011-10-20       Impact factor: 9.776

5.  Synthesis of bisethylnorspermine lipid prodrug as gene delivery vector targeting polyamine metabolism in breast cancer.

Authors:  Yanmei Dong; Yu Zhu; Jing Li; Qing-Hui Zhou; Chao Wu; David Oupický
Journal:  Mol Pharm       Date:  2012-04-30       Impact factor: 4.939

6.  Reducible HPMA-co-oligolysine copolymers for nucleic acid delivery.

Authors:  Julie Shi; Russell N Johnson; Joan G Schellinger; Peter M Carlson; Suzie H Pun
Journal:  Int J Pharm       Date:  2011-08-27       Impact factor: 5.875

7.  Non-covalent ligand conjugation to biotinylated DNA nanoparticles using TAT peptide genetically fused to monovalent streptavidin.

Authors:  Wenchao Sun; David Fletcher; Rolf Christiaan van Heeckeren; Pamela B Davis
Journal:  J Drug Target       Date:  2012-09       Impact factor: 5.121

8.  Iterative Reducible Ligation to form Homogeneous Penicillamine Cross-linked Polypeptides.

Authors:  Mark D Ericson; Kevin G Rice
Journal:  Tetrahedron Lett       Date:  2013-06-26       Impact factor: 2.415

Review 9.  A review of the tortuous path of nonviral gene delivery and recent progress.

Authors:  Divya Sharma; Sanjay Arora; Jagdish Singh; Buddhadev Layek
Journal:  Int J Biol Macromol       Date:  2021-06-01       Impact factor: 8.025

10.  Reducible PEG-POD/DNA Nanoparticles for Gene Transfer In Vitro and In Vivo: Application in a Mouse Model of Age-Related Macular Degeneration.

Authors:  Bhanu Chandar Dasari; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-10       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.